Preoperative radiotherapy downregulates the nuclear expression of hypoxia-inducible factor-1α in rectal cancer

References

• Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005;16:481–8.
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182–6.
   PubMed Web of Science ®Google Scholar
• Dachs G, Stratford I. The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy. Br J Cancer Suppl 1996;27:S126–32.
   PubMedGoogle Scholar
• Semenza G. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721–32.
   PubMed Web of Science ®Google Scholar
• Semenza G. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 2000;35:71–103.
   PubMed Web of Science ®Google Scholar
• Höckel M, Schlenger K, Mitze M, Schäffer U, Vaupel P. Hypoxia and radiation response in human tumors. Semin Radiat Oncol 1996;6:3–9.
   PubMed Web of Science ®Google Scholar
• Harris A. Hypoxia–-a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38–47.
   PubMed Web of Science ®Google Scholar
• Wang G, Semenza G. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 1993;268:21513–8.
   PubMed Web of Science ®Google Scholar
• Greijer A, Delis-van Diemen P, Fijneman R, Giles R, Voest E, van Hinsbergh V, Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum. Virchows Arch 2008;452:535–44.
   PubMedGoogle Scholar
• Wang G, Semenza G. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 1993;90:4304–8.
   PubMed Web of Science ®Google Scholar
• Wang G, Jiang B, Rue E, Semenza G. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 1995;92:5510–4.
   PubMed Web of Science ®Google Scholar
• Koukourakis M, Giatromanolaki A, Polychronidis A, Simopoulos C, Gatter K, Harris A, Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer. Cancer Sci 2006;97:582–8.
   PubMed Web of Science ®Google Scholar
• Maxwell P, Pugh C, Ratcliffe P. Activation of the HIF pathway in cancer. Curr Opin Genet Dev 2001;11:293–9.
   PubMed Web of Science ®Google Scholar
• Jaakkola P, Mole D, Tian Y, Wilson M, Gielbert J, Gaskell S, Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001;292:468–72.
   PubMed Web of Science ®Google Scholar
• Weidemann A, Johnson R. Biology of HIF-1alpha. Cell Death Differ 2008;15:621–7.
   PubMed Web of Science ®Google Scholar
• Theodoropoulos G, Lazaris A, Theodoropoulos V, Papatheodosiou K, Gazouli M, Bramis J, Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer. Int J Colorectal Dis 2006;21:248–57.
   PubMedGoogle Scholar
• Lu X, Xing C, Feng Y, Chen J, Deng C. Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma. Clin Colorectal Cancer 2006;5:350–3.
   PubMed Web of Science ®Google Scholar
• Koukourakis M, Giatromanolaki A, Sivridis E, Simopoulos C, Turley H, Talks K, Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002;53:1192–202.
   PubMed Web of Science ®Google Scholar
• Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509–15.
   PubMed Web of Science ®Google Scholar
• Korkeila E, Talvinen K, Jaakkola P, Minn H, Syrjänen K, Sundström J, Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer. Br J Cancer 2009;100:874–80.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Dicato M, Wils J, Cunningham D, Diaz-Rubio E, Glimelius B, Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001). Eur J Cancer 2002;38:1429–36.
   PubMedGoogle Scholar
• Jokilehto T, Rantanen K, Luukkaa M, Heikkinen P, Grenman R, Minn H, Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness. Clin Cancer Res 2006;12:1080–7.
   PubMed Web of Science ®Google Scholar
• Wiesener M, Münchenhagen P, Berger I, Morgan N, Roigas J, Schwiertz A, Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res 2001;61:5215–22.
   PubMed Web of Science ®Google Scholar
• Rödel C, Martus P, Papadoupolos T, Füzesi L, Klimpfinger M, Fietkau R, Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688–96.
   PubMed Web of Science ®Google Scholar
• Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997;12:19–23.
   PubMed Web of Science ®Google Scholar
• Semenza G, Roth P, Fang H, Wang G. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994;269:23757–63.
   PubMed Web of Science ®Google Scholar
• Ravizza R, Molteni R, Gariboldi M, Marras E, Perletti G, Monti E. Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil. Eur J Cancer 2009;45:890–8.
   PubMedGoogle Scholar
• Appelhoff R, Tian Y, Raval R, Turley H, Harris A, Pugh C, Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 2004;279:38458–65.
   PubMed Web of Science ®Google Scholar
• Koukourakis M, Giatromanolaki A, Sivridis E, Pastorek J, Karapantzos I, Gatter K, Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;59:67–71.
   PubMed Web of Science ®Google Scholar
• Cleven A, van Engeland M, Wouters B, de Bruïne A. Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas. Cell Oncol 2007;29:229–40.
   PubMed Web of Science ®Google Scholar
• Yoshimura H, Dhar D, Kohno H, Kubota H, Fujii T, Ueda S, Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin Cancer Res 2004;10:8554–60.
   PubMed Web of Science ®Google Scholar
• Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000;60:4693–6.
   PubMed Web of Science ®Google Scholar
• Brizel D, Scully S, Harrelson J, Layfield L, Bean J, Prosnitz L, Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996;56:941–3.
   PubMed Web of Science ®Google Scholar
• Semenza G. Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov Today 2007;12:853–9.
   PubMed Web of Science ®Google Scholar